Mars,
The manner in which the EBIT targets have been presented (i.e., wrt a FY15 base year) is highly unorthodox and the cynic in me tells me that it is designed that way to confound the less-diligent follower of the company.
Certainly, figures of "10% or 15% compared to base year" certainly come across a far more palatable at first glance than does "~5% pa".
PS. For context, I note that IFM has grown EBIT annual rates of by 8%, 29% and 13% pa over the past 3 financial years, so for the board to actively be designing a remuneration structure around a rate that is waaaaay below recent history begs a lot of questions.
At first pass, it smacks to me to being egregiously generous!
(And besides, a pure EBIT number - in isolation - is not a very useful determinant of shareholder wealth creation (management could simply acquire a whole swathe of EBIT at a silly multiple and they will get to where they want to be.)
I have some form in the past of operating in an activist capacity when the circumstances have warranted it.
To that end, I have built a financial model for IFM but I have not followed the executive travails of the business as well I sense you have.
When you have a moment, could you provide a thumbnail sketch of the sequence of events that led to the company coming to the position it currently finds itself, namely with the good guys seemingly sitting on the outside? I am assuming the founder stepped aside at some stage only to have the board morph into something he today finds incompatible with the interests of the company's shareholders.
- Forums
- ASX - By Stock
- IFM
- Richard Graham email regarding Performance Rights
IFM
infomedia ltd
Add to My Watchlist
2.34%
!
$1.20

Richard Graham email regarding Performance Rights, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.028(2.34%) |
Mkt cap ! $444.6M |
Open | High | Low | Value | Volume |
$1.19 | $1.22 | $1.19 | $143.6K | 119.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 669 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 3908 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 775 | 1.200 |
4 | 9258 | 1.195 |
2 | 218402 | 1.190 |
3 | 2780 | 1.185 |
2 | 2335 | 1.180 |
Price($) | Vol. | No. |
---|---|---|
1.205 | 3908 | 8 |
1.210 | 27166 | 4 |
1.215 | 1940 | 2 |
1.220 | 3342 | 3 |
1.225 | 22744 | 2 |
Last trade - 10.39am 02/07/2025 (20 minute delay) ? |
Featured News
IFM (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online